Sclerostin Antibody Reverses the Severe Sublesional Bone Loss in Rats After Chronic Spinal Cord Injury

To date, no efficacious therapy exists that will prevent or treat the severe osteoporosis in individuals with neurologically motor-complete spinal cord injury (SCI). Recent preclinical studies have demonstrated that sclerostin antibody (Scl-Ab) can prevent sublesional bone loss after acute SCI in ra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Calcif Tissue Int
Main Authors: Zhao, Wei, Li, Xiaodong, Peng, Yuanzhen, Qin, Yiwen, Pan, Jiangping, Li, Jiliang, Xu, Aihua, Ominsky, Michael S., Cardozo, Christopher, Feng, Jian Q., Ke, Hua Zhu, Bauman, William A., Qin, Weiping
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7891854/
https://ncbi.nlm.nih.gov/pubmed/29931461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-018-0439-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados